This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
Mark Your Calendar for This Year's Event!
September 27-30, 2022Boston Convention and Exhibition Center

Ali Mohamed
VP, CMC at Immatics


Ali Mohamed, PhD, Vice President, CMC, Immatics US Inc in Houston TX currently leading the development and manufacturing of various Adoptive Cell Therapies. Dr. Mohamed has more than 20 years of experience in process development and GMP manufacturing of regenerative medicine, cell and gene therapy products at various CMOs and clinical stage companies. Before joining Immatics, Dr.  Mohamed was the senior director of manufacturing operations/ manufacturing development at PCT (Hitachi Chemical Advanced Therapeutics Solutions) helping various companies manufacture cell in gene therapy products.

Dr. Mohamed holds a PhD in Molecular Pharmacology from Medical College of Ohio (Currently the University of Toledo Medical College) and postdoctoral fellowship in neuroscience and neurobiology from the Georgetown University Institute of Cognitive and Computational Sciences.

Agenda Sessions

  • Manufacturing process optimization during early- and late-stage development

  • PANEL: Let’s Settle the Debate – Can Auto and Allo Therapies Co-Exist

  • Chairperson’s Opening remarks


Speakers at this event